If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
3-Bromomethyl-1-chloro-4-(4-methoxy-2-nitrophenoxy)benzene
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1215782-19-63-Bromomethyl-1-chloro-4-(4-methoxy-2-nitrophenoxy)benzene

● In Stock

Catalogue No.:VE0021377
CAS No.:1215782-19-6
Mol. Formula:C14H11BrClNO4
Mol. Weight:372.6 g/mol

Additional information on CAS 1215782-19-6

Parent drug

Loxapine

IUPAC Name

3-Bromomethyl-1-chloro-4-(4-methoxy-2-nitrophenoxy)benzene

Pharmacopoeial Synonyms

N/A

Other Synonyms

1-[2-(bromomethyl)-4-chlorophenoxy]-4-methoxy-2-nitrobenzene

Smiles

O=[N+](C1=CC(OC)=CC=C1OC2=CC=C(Cl)C=C2CBr)[O-]

Description

3-Bromomethyl-1-chloro-4-(4-methoxy-2-nitrophenoxy)benzene | also known as 1-[2-(bromomethyl)-4-chlorophenoxy]-4-methoxy-2-nitrobenzene | is a highly characterized reference material. It fully complies with stringent regulatory standards | including those set by USP | EMA | JP | and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial production of Loxapine. Moreover | it comes with a detailed Structure Elucidation Report (SER) | ensuring its accuracy and reliability for a wide range of analytical applications.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form